Medpace appoints Jesse Geiger as President, Kevin Brady as CFO effective Aug 1

Medpace Holdings, Inc.

Jesse Geiger, formerly CFO and COO of laboratory ops, becomes President; August Troendle remains Chairman & CEO.
Kevin Brady, formerly Executive Director of Finance and Treasurer, promoted to CFO effective August 1, 2021.
Brady's CFO compensation: $340,000 annual base salary plus short-term and long-term incentive eligibility.
Brady will continue as Treasurer and report to Geiger; Geiger reports to Troendle.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jesse J. Geiger

President

MEDP · Medpace Holdings, Inc.

Effective: 2021-08-01
Filed: July 26, 2021, 7:59 PM ET

appointments of Jesse J. Geiger to the position of President

Role change

Kevin M. Brady

Chief Financial Officer

MEDP · Medpace Holdings, Inc.

Effective: 2021-08-01
Filed: July 26, 2021, 7:59 PM ET

Kevin M. Brady to the position of Chief Financial Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jesse J. Geiger was appointed as President at Medpace Holdings, Inc..

Action: appointed
Role: President

Exact text from the filing

appointments of Jesse J. Geiger to the position of President

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin M. Brady was appointed as Chief Financial Officer at Medpace Holdings, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Kevin M. Brady to the position of Chief Financial Officer

View on SEC.gov

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-224356

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.